Company Encyclopedia
View More
name
Illumina
ILMN.US
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services.
770.89 B
ILMN.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Life Sciences Tools and ServicesIndustry
Industry Ranking19/60
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE31.20%A
    • Profit Margin16.39%A
    • Gross Margin69.10%A
  • Growth ScoreC
    • Revenue YoY-2.32%D
    • Net Profit YoY144.35%A
    • Total Assets YoY2.71%C
    • Net Assets YoY12.05%B
  • Cash ScoreC
    • Cash Flow Margin609.96%C
    • OCF YoY-2.32%D
  • Operating ScoreB
    • Turnover0.7B
  • Debt ScoreD
    • Gearing Ratio61.45%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Illumina Inc. Stock Underperforms Monday When Compared To Competitors

    Illumina Inc. (ILMN) shares fell 2.08% to $128.72 on Monday, ending a five-day winning streak, amid a broader market downturn. The S&P 500 Index dropped 0.53% and the Dow Jones Industrial Average fell 0.90%. Illumina's stock is 15.90% below its 52-week high of $153.06. Competitors like Labcorp, Charles River Laboratories, and Quest Diagnostics also saw declines.

    Dow Jones·
    US
    ILMN
    +0.06%
    Dow Jones·
    US
    ILMN
    +0.06%

    Illumina, Inc. $ILMN Shares Purchased by Coldstream Capital Management Inc.

    Coldstream Capital Management Inc. increased its stake in Illumina, Inc. by 222.9% in Q2, owning 3,823 shares worth $365,000. Other investors also boosted their positions. Illumina's stock opened at $131.39, with a market cap of $20.08 billion. Analysts have mixed ratings, with a consensus price target of $115.00. Illumina reported Q3 earnings of $1.34 per share, beating estimates.

    Market Beat·
    US
    ILMN
    +0.06%
    Market Beat·
    US
    ILMN
    +0.06%

    North Star Asset Management Inc. Boosts Stock Position in Illumina, Inc. $ILMN

    North Star Asset Management Inc. increased its stake in Illumina, Inc. by 16.5% in Q2, owning 130,804 shares valued at $12.48 million. Other institutional investors also adjusted their positions. Illumina's stock has a consensus 'Hold' rating with a target price of $115.00. The company reported Q3 earnings of $1.34 per share, surpassing estimates, with revenue of $1.08 billion.

    Market Beat·
    US
    ILMN
    +0.06%
    Market Beat·
    US
    ILMN
    +0.06%

    Handelsbanken Fonder AB Sells 47,932 Shares of Illumina, Inc. $ILMN

    Handelsbanken Fonder AB reduced its stake in Illumina, Inc. by 54.3% in Q2, selling 47,932 shares. Illumina's stock has mixed analyst ratings, with a current average rating of "Hold" and a target price of $115.00. The stock opened at $125.96, with a 12-month range of $68.70 to $153.06. Illumina reported Q3 earnings of $1.34 per share, exceeding expectations.

    Market Beat·
    US
    ILMN
    +0.06%
    Market Beat·
    US
    ILMN
    +0.06%

    Illumina Raises $500 Million in 4.75% Notes Offering

    Illumina Inc. has raised $500 million through a public offering of 4.750% notes due 2030. The proceeds will be used for general corporate purposes, including potential repayment of existing notes and acquisition costs. Interest is payable semi-annually, with maturity on December 12, 2030.

    Reuters·
    US
    ILMN
    +0.06%
    Reuters·
    US
    ILMN
    +0.06%
    Posts
    View More

    News verification $XTALPI(02228.HK) The news you mentioned is basically accurate. I have cross-verified it through multiple reliable sources (such as the company's official press releases, Yahoo Finan......

    © 2025 Longbridge｜Disclaimer